Don’t start life science investing until you read this!
This report is free. No credit card required.
What you will learn when you read Life Science Investing Primer – Finding More Opportunities like Medtronic, Ariad Pharmaceuticals and Pharmacyte
What if you don’t want to invest directly in companies like Medtronic and Pfizer?
This free Special Report covers all the bases for investors interested in life sciences. If you don’t want to invest in companies directly, you might want to chose to invest in an ETF, an exchange-traded fund covering many life science stocks.
A recent report from Barron’s maintains that since the beginning of 2014, healthcare has outpaced every other sector in the S&P 500, not to mention the broader stock market as a whole. The healthcare sector has been seeing major gains since 2010. In fact, a 2013 report from CNBC and Yahoo Finance showed that if you used the SPDR Health Care ETF as a measure, which includes Johnson & Johnson and Medtronic, healthcare companies have experienced gains of nearly 64 percent since March 23, 2010, eclipsing the 52 percent rise posted by the S&P 500.
In all, there simply is no other single resource that brings together the best current information on life science investing, whether you’re a novice healthcare investor or an old hand. This free Special Report, Life Science Investing Primer, is, if you’ll pardon the pun, just what the doctor ordered! Download it today!
And at this price – $0.00 – it’s certainly affordable! Don’t waste another minute wondering how what company is going to be the next Ariad Pharmaceuticals and Pharmacyte, or in trying to sift through the onslaught of information – some of it valuable, much of it not – on your own. Read our Special Report today, and start making savvy investing decisions tomorrow!
We’re pleased to be able to make it available to you at no cost, and hope you’ll take advantage of the expertise it delivers.
Yours for profitable, healthy investing,
Publisher & CEO
Investing News Network
PS: Did I mention that this Special Report also includes numerous links to additional insight – information you might never find on your own? This is the kind of guidance that’s a deal at any price — but especially when it’s FREE. Download it today!
PPS: Here at Life Science Investing Network, we have no hidden, vested interest in getting you to invest in life science companies. This report was not sponsored by Medtronic. We simply believe investors like you deserve the best professional guidance available, and we just happen to deliver it for free in this Special Report. Read it now!